Dear Sir or Madame,
Could you advise me please how bigger is the risk of developing breast cancer if one hasthe diagnosis of a Lobular carcinoma in situ floride with comedonecrosis? I know that for the classic Lobular carcinoma in situ the risk is around 15-20%. Are there any alternative treatment options apart from surgery?
Thank you and best regards,
Karina
Dear Karina,
Thanks for getting in touch and welcome to our online community. I see that you’re a member of our online breast cancer forum. I hope it will be a good source of support.
It’s understandable to have questions about treatment, and about the significance of information included in pathology reports. These often include very technical information, which is often best explained by a member of the specialist breast team.
The American Cancer Society have this information about lobular carcinoma in situ (LCIS) and explain some of the other features that pathologists look for.
I’m not sure from your post if surgery has been recommended. Sometimes it helps to ask if a particular treatment has been recommended after a multidisciplinary team meeting. It’s often reassuring to hear that treatment has been recommended by a group of specialists.
As nurses on this type of platform, we can’t make recommendations about treatment because we don’t have access to medical notes.
However Up To Date, which is an American clinical decision making aid recommend that ‘surgical excision is recommended for any nonclassic LCIS (ie, pleomorphic LCIS, florid LCIS)’.
I hope this is helpful.
Best wishes,
Carole (Cancer Information Nurse Specialist)
You can also speak with the Macmillan Support Line team of experts. Phone free on 0808 808 0000 (7 days a week, 8am-8pm) or send us an email.
Our ref: AM
